antiplatelet

(redirected from Antiplatelet drug)
Also found in: Medical, Wikipedia.

an·ti·plate·let

 (ăn′tē-plāt′lĭt, ăn′tī-)
adj.
Acting against or destroying blood platelets.
Mentioned in ?
References in periodicals archive ?
Even when handed information on whether each clopidogrel-treated patient was a poor metabolizer of the drug, treating physicians usually did not switch them to a different antiplatelet drug, ticagrelor, that would be fully effective despite the patient's reduced-metabolizer status.
The settlement alleges that the company misrepresented its antiplatelet drug, Aggrenox, that was effective for many conditions 'below the neck,' such as heart attacks and congestive heart failure, and that it was superior to Plavix, without evidence to substantiate that claim; misrepresented that Micardis protected patients from early morning strokes and heart attacks and treated metabolic syndrome; misrepresented that Combivent could be used as a first-line treatment for bronchospasms associated with chronic obstructive pulmonary disease (COPD); Falsely stated that Atrovent and Combivent could be used at doses that exceeded the maximum dosage recommendation in the product labelling and that the drugs were essential for treatment of COPD.
Specifically, the States allege BIPI: (1) misrepresented that its antiplatelet drug, Aggrenox, was effective for many conditions below the neck, such as heart attacks and congestive heart failure, and that it was superior to Plavix without evidence to substantiate that claim; (2) misrepresented that Micardis protected patients from early morning strokes and heart attacks and treated metabolic syndrome; (3) misrepresented that Combivent could be used as a first-line treatment for bronchospasms associated with chronic obstructive pulmonary disease (COPD); and (4) falsely stated that Atrovent and Combivent could be used at doses that exceeded the maximum dosage recommendation in the product labeling and that they were essential for treatment of COPD.
Rivaroxaban, often known by the brand name Xarelto, is an anticoagulant, aspirin is an antiplatelet drug, and both are blood thinners.
Aspirin helps prevent platelets in the bloodstream from clumping together and forming a clot, so it is called an antiplatelet drug; other antiplatelet drugs include Clopidogrel (Plavix) and ticagrelor (Brilinta).
The antiplatelet drug reduced the risk of the composite endpoint by 32%, compared with aspirin, in stroke patients with proven ipsilateral atherosclerotic stenosis (hazard ratio, 0.
conducted a prospective clinical study by performing simple dental extractions on 43 patients taking 2 anti-platelet drugs, mostly aspirin and clopidogrel and 117 patients taking a single antiplatelet drug in the form of aspirin, clopidogrel and ticlopidine.
Due to antiplatelet drug the density of blood gets thinner and leads to the motion of fluid freely inside the arteries.
The landmark Plato study showed that, compared to the standard antiplatelet drug clopidogrel, an additional one patient life is saved for every 100 patients treated with ticareglor, said Dr Emmanuel Arca, AstraZeneca Philippines associate medical director.
For example, in the case of a systemic infection, an antiplatelet drug may be used to modulate platelet recruitment of T cells, allowing antibiotic therapy to resolve the infection.
Despite the use of these drugs, ischemic events recur in considerable number of patients due to development of antiplatelet drug resistance.
Drug manufacturer Abbott Laboratories Philippines has announced a voluntary recall of its antiplatelet drug after it confirmed damage of its refrigerator system that may have affected the drug.